Development of Matrix Tablets for Diabetes Treatment
Author Information
Author(s): Sha’at Mousa, Ochiuz Lacramioara, Rusu Cristina Marcela, Agop Maricel, Barsan (Bujor) Alexandra, Cretan Monica Stamate, Hartan Mihaela, Spac Adrian Florin
Primary Institution: “Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania
Hypothesis
The study aims to develop and characterize extended-release polymeric matrix tablets containing metformin hydrochloride and honokiol to enhance glycemic control.
Conclusion
The study successfully developed dual-drug extended-release matrix tablets, demonstrating the potential of hydrophilic polymers to regulate drug release and improve diabetes management.
Supporting Evidence
- The study revealed distinct release profiles for metformin hydrochloride and honokiol.
- M-HCl exhibited a rapid release phase, while HNK demonstrated a slower release profile.
- Mathematical modeling validated the experimental findings and provided insights into drug release mechanisms.
- Higher polymer concentrations resulted in slower drug release rates.
Takeaway
Researchers created special tablets that release diabetes medicine slowly, helping people manage their blood sugar better.
Methodology
The tablets were formulated using hydrophilic polymers and their release kinetics were studied through in vitro dissolution tests and mathematical modeling.
Statistical Information
P-Value
0.041
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website